Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02226016
Other study ID # LEVATOR01
Secondary ID
Status Not yet recruiting
Phase N/A
First received August 11, 2014
Last updated August 23, 2014
Start date September 2014
Est. completion date September 2015

Study information

Verified date August 2014
Source Meir Medical Center
Contact Nemet Arik, DR
Phone +972-9747-2154
Email nemet.arik@gmail.com
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess a new technique of measurement for the levator muscle.

this measurement may be applied during a clinical evaluation of eyelid malposition.

our purpose is to quantify the levator muscle strength and to corelate it to standard levator muscle strength assessment techniques routinley used in the oculoplastic clinic.


Description:

This study will include patients refered to our oculoplastic department for evaluation of eyelid disorders (ptosis or eyelid malpositions due to various mechanical, muscular, neurogenic factors).

all patients will be over 21 years old, with eligibility for signing an informed concent form.

all patients will undergo a full clinical standard evaluation of eyelid malposition made as part of the routine evaluation of eyelid malpositions. as part of this evaluation- the levator muscles strength will be measured by monitoring the amount of millimeters of difference between the uper lid closed and open position (a regular technique for levator muscles assessment).

a second levator muscle strength evaluation will include the study device. this device is used for weight evaluation of objects. an object is measured by attaching it to the device with a metal hook and a string. the device is hand held.

for measurements of the upper lid force the device will be temporarily attached to the upper eyelid using a specially designed base made in the shape of the eyelid. the attachment will be using a sterile medical tape (plaster). this sterile base is attached to the outer eyelid and does not involve in any point any harm to the continuity of the skin, injections , harm or contact to the eyeball or any other parts of the eye. this base is attached from its back to a string witch attaches to the measuring device. the investigator holds the measuring device and asks the patient to open and close his eyes. the force that is generated while opening the upper lid is measured (in grams) by the device.

this evaluation will allow a unique first proper estimation of the true levator palpebra strength. it will be compared to the levators' strength as estimated using the routine techniques for assessing their efficacy.

the assessment will be made one time for each patient. after the measurement- the sterile tape will be removed and will be disposed. no further interventions will be made for each patient.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date September 2015
Est. primary completion date September 2015
Accepts healthy volunteers No
Gender Both
Age group 21 Years and older
Eligibility Inclusion Criteria:

eligible for signing an informed concent form refered for eyelid evaluation in the oculoplastic department, Meir Mc

Exclusion Criteria:

previous eyelid surgery

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
FG-5000A
a measuring device for the assessment of levator muscle strength

Locations

Country Name City State
Israel Meir Medical center Kfar Saba

Sponsors (1)

Lead Sponsor Collaborator
Meir Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary levator muscle strength quantified in grams using a unique measuring device. we aim to accurately measure the levator muscle strength in grams. the levator muscle will be noninvasively attached to the device using a string. while changing eye position from closure to opening- the force generated by the eyelid will be reflected through the string to the measuring device and will be displayed in grams. this will reflect the levator muscles strength. each patient will undergo two measurments of the levator muscle strength using the study device during a single clinical evaluation. no further evaluations will be made for the same patient throughout the study. No
Secondary repeatability of the measurements we wish to evaluate the validity of these muscle strength assessments. for each patient two muscle measurements will be done by a single clinician. their results will be furtherly assessed for repeatability of the measurement. each patient will undergo two measurments of the levator muscle strength using the study device during a single clinical evaluation. no further evaluations will be made for the same patient throughout the study. No
See also
  Status Clinical Trial Phase
Completed NCT01430247 - Vision Screening for the Detection of Amblyopia N/A
Recruiting NCT02959697 - Subconjunctival Injection of Local Anesthetic in Anterior Blepharoptosis Repair N/A
Terminated NCT02878694 - Treatment of Ptosis to Muscular Dystrophy Oculopharyngeal by Myoblast Autologous Graft Phase 2/Phase 3
Recruiting NCT04714424 - Comparing Vision Tests in a Virtual Reality Headset to Existing Analogues
Not yet recruiting NCT04007276 - The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients Phase 4
Withdrawn NCT02761083 - PMCF-study Using Novosyn® Quick Suture Material in Ophthalmic Surgery Phase 4
Completed NCT02376556 - The Effect of Eyelid Surgery on Dry Eye - a Prospective Study
Completed NCT02201979 - Laser Fluorescent Imaging of Nipple and Areola During Breast Lift N/A
Recruiting NCT03375879 - Bandage Contact Lens in Post Operative Ptosis Patients N/A
Recruiting NCT05746078 - Performance and Safety Assessment of SPRING THREAD® Elastic Tensor Thread in Patients With Mild to Moderate Facial Ptosis.
Withdrawn NCT03266081 - Bupivacaine Epiphora Trial Phase 2